Literature DB >> 2526123

Biosynthetic analysis of the human interferon-gamma receptor. Identification of N-linked glycosylation intermediates.

G K Hershey1, R D Schreiber.   

Abstract

Biosynthesis of the human IFN gamma receptor was studied using metabolic labeling techniques and immunoprecipitation with receptor-specific monoclonal antibodies. Colo-205 and HepG2 cells labeled with [35S]methionine gave rise to two components with molecular mass 75 and 90 kDa following sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No bands were detected when immunoprecipitation was performed using irrelevant monoclonal IgG or in the presence of excess ligand, a condition known to block antibody-receptor interaction. When Colo-205 were labeled for increasing periods of time, the 75-kDa form was detected after 5 min, whereas the 90-kDa form appeared only after 60 min. Pulse-chase analysis established that the 75-kDa form was the precursor of the 90-kDa component. Only the 90-kDa form was detected on extrinsically radioiodinated Colo-205 cell surfaces. This observation was confirmed by Western blot analysis of isolated Colo-205 membranes. Digestion of labeled precipitates with peptide:N-glycosidase F caused a 22% reduction in the apparent molecular weight of the IFN gamma receptor. Receptor derived from tunicamycin-treated Colo-205 labeled for 5 min displayed a single molecular mass of 65 kDa and expressed ligand binding activity. Longer labeling periods in the presence of tunicamycin revealed the appearance of a second ligand-binding form of 70 kDa. Thus, Colo-205 IFN gamma receptors carry asparagine (N)-linked oligosaccharides and possibly some other form of post-translational modification.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

Authors:  Elise Alspach; Danielle M Lussier; Robert D Schreiber
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

2.  Cloning and expression of the cDNA for the murine interferon gamma receptor.

Authors:  P W Gray; S Leong; E H Fennie; M A Farrar; J T Pingel; J Fernandez-Luna; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases.

Authors:  Ashley R Maiuri; Anna B Breier; Lukas F J Gora; Robert V Parkins; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2015-05-07       Impact factor: 4.849

4.  Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor.

Authors:  M A Farrar; J D Campbell; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.

Authors:  K C Sheehan; J K Pinckard; C D Arthur; L P Dehner; D V Goeddel; R D Schreiber
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

6.  Post-translational modification of the interferon-gamma receptor alters its stability and signaling.

Authors:  James D Londino; Dexter L Gulick; Travis B Lear; Tomeka L Suber; Nathaniel M Weathington; Luke S Masa; Bill B Chen; Rama K Mallampalli
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

7.  A receptor for interleukin 10 is related to interferon receptors.

Authors:  A S Ho; Y Liu; T A Khan; D H Hsu; J F Bazan; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).

Authors:  A C Greenlund; M A Farrar; B L Viviano; R D Schreiber
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

Review 9.  Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma.

Authors:  Fransien van Dijk; Peter Olinga; Klaas Poelstra; Leonie Beljaars
Journal:  Front Med (Lausanne)       Date:  2015-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.